找到约 2 条 “DCC-2618” 相关结果 （用时 0.334 秒）
| 目录号 | 产品名称 | 中文名称 | 靶点 |
|---|---|---|---|
M9903
|
Ripretinib | 瑞派替尼 | c-Kit |
| DCC-2618 | |||
| Ripretinib（DCC-2618）是一种具有口服活性的，选择性的KIT和PDGFR-alpha抑制剂。 | |||
| M20635 | DCC-2618 | DCC-2618 | c-Kit |
| DCC-2618 is an orally bioavailable switch pocket control inhibitor of wild-type and mutated forms of KIT and PDGFR with potential antineoplastic activity. It also inhibits several other kinases, including VEGFR2, TIE2, PDGFR-beta and CSF1R, thereby further inhibiting tumor cell growth. | |||
